Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Treating hyperprolactinemia can help manage PCOS symptoms.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

Evaluate prolactin levels with androgen and thyroid tests to rule out endocrine issues in patients with SAHA syndrome symptoms.

Clinical features of hyperandrogenism do not predict the success of conventional acne treatment in women.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Testosterone may influence COVID-19 severity and outcomes.

Endocrine diseases in children can cause various skin and hair changes.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Androgen levels increase with puberty and are linked to sexual hair development.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Gut bacteria can lower androgen levels in male mice.

Early onset hair loss linked to genetics and androgen levels.

Men with testicular cancer were less likely to experience baldness and severe acne.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Balding men had lower bone density, while balding women had higher hip bone density.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.